Fc. Riess et al., BEATING HEART OPERATIONS INCLUDING HYBRID REVASCULARIZATION - INITIALEXPERIENCES, The Annals of thoracic surgery, 66(3), 1998, pp. 1076-1081
Citations number
20
Categorie Soggetti
Surgery,"Cardiac & Cardiovascular System","Respiratory System
Background. The outcome of patients (n = 45) with coronary one- to thr
ee-vessel disease undergoing beating heart operations using a recently
developed stabilizing device was investigated. Methods. Left internal
mammary artery-to-left anterior descending coronary artery (LIMA-to-L
AD) revascularization was carried out alone (n = 31) or as hybrid proc
edure in combination with a balloon angioplasty (n = 14). Results. All
45 patients underwent a successful LIMA-to-LAD procedure without intr
aoperative complication during a 21 +/- 8-minute (range, 10 to 53 minu
tes) LAD occlusion time. In 14 hybrid procedures a total of 19 stenose
s including 3 left main stenoses were treated successfully by percutan
eous transluminal coronary angioplasty and stenting. The postoperative
courses were uneventful with the exception of two surgical reexplorat
ions necessitated by bleeding. No worsening of renal, neurologic, or r
espiratory functions occurred in any patient. In the group having a si
ngle LIMA-to-LAD procedure, early postoperative coronary angiograms (2
2 of 31) showed a patent LIMA graft and excellent anastomosis; this wa
s also true in 4 patients 12 months after operation as shown in angiog
rams. All patients undergoing hybrid revascularization demonstrated a
patent LIMA-to-LAD anastomosis; in I patient there was a dissection in
the midlevel of the LIMA, which was stented successfully. The 6-month
follow-up angiograms in 7 of 14 patients revealed open LIMA bypass gr
afts in all patients except 1, who was stented because of dissection.
Conclusions. These data indicate that a beating heart operation includ
ing hybrid revascularization is safe and effective in selected patient
s with coronary one- to three-vessel disease including left main steno
sis, This approach may be especially advantageous in comparison with c
onventional coronary artery bypass grafting in patients with severe co
ncomitant disease.